Trial intelligence / Profile preview

Conventional ovarian stimulation vs single Corifollitropin alfa injection in oocyte donors

2019-001343-44Phase 4Completed

Sponsor
Instituto Bernabeu
Start
Apr 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of corifollitropin alfa (2 arms), sponsored by Instituto Bernabeu. Primary endpoint: Number of oocytes. Started Apr 2019; status: completed.

02

Drugs

corifollitropin alfa

Beyond the preview

Go deeper on 2019-001343-44.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-001343-44.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call